Transcriptome profiling of influenza A virus-nfected lung epithelial (A549) cells with lariciresinol-4-β-D-glucopyranoside treatment

被引:28
|
作者
Zhou, Beixian [1 ]
Li, Jing [2 ]
Liang, Xiaoli [2 ]
Yang, Zifeng [1 ,2 ]
Jiang, Zhihong [1 ]
机构
[1] Macau Univ Sci & Technol, Macau Inst Appl Res Med & Hlth, State Key Lab Qual Res Chinese Med, Taipa, Macau, Peoples R China
[2] Guangzhou Med Univ, Affiliated Hosp 1, Natl Clin Ctr Resp Dis, State Key Lab Resp Dis,Guangzhou Inst Resp Dis, Guangzhou, Guangdong, Peoples R China
来源
PLOS ONE | 2017年 / 12卷 / 03期
基金
中国国家自然科学基金;
关键词
TRADITIONAL CHINESE MEDICINE; DNA-DAMAGE-RESPONSE; ISATIS-INDIGOTICA; TELOMERE LENGTH; CYCLE ARREST; ANTIVIRAL ACTIVITY; I INTERFERON; IKK-EPSILON; INFECTION; EXPRESSION;
D O I
10.1371/journal.pone.0173058
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
The influenza A virus is an acute contagious pathogen that affects the human respiratory system and can cause severe lung disease and even death. Lariciresino1-4-beta-D-glucopyranoside is a lignan that is extracted from Isatis indigotica, which is a medicinal herb plant that was commonly applied to treat infections, the common cold, fever and inflammatory diseases. Our previous study demonstrated that lariciresino1-4-beta-D-glucopyranoside possesses anti-viral and anti-inflammatory properties. However, the comprehensive and detailed mechanisms that underlie the effect of lariciresino1-4-beta-D-glucopyranoside interventions against influenza virus infection remain to be elucidated. In this study, we employed high-throughput RNA sequencing (RNA-seq) to investigate the transcriptomic responses of influenza A virus-infected lung epithelial (A549) cells with lariciresino1-4-beta-D-glucopyranoside treatment. The transcriptome data show that infection with influenza A virus prompted the activation of 368 genes involved in RIG-I signalling, the inflammatory response, interferon a/beta signalling and gene expression that was not affected by lariciresino1-4-beta-D-glucopyranoside treatment. Lariciresino1-4-beta-D-glucopyranoside exerted its pharmacological actions on the immune system, signal transduction, cell cycle and metabolism, which may be an underlying defense mechanism against influenza virus infection. In addition, 166 differentially expressed genes (DEGs) were uniquely expressed in lariciresino1-4-beta-D-glucopyranoside-treated cells, which were concentrated in the cell cycle, DNA repair, chromatin organization, gene expression and biosynthesis domains. Among them, six telomere-associated genes were up-regulated by lariciresino1-4-beta-D-glucopyranoside treatment, which have been implicated in telomere regulation and stability. Collectively, we employed RNAseq analysis to provide comprehensive insight into the mechanism of lariciresino1-4-beta-D-glucopyranoside against influenza virus infection.
引用
收藏
页数:22
相关论文
共 22 条
  • [21] Resolvin D1 inhibits TGF-β1-induced epithelial mesenchymal transition of A549 lung cancer cells via lipoxin A4 receptor/formyl peptide receptor 2 and GPR32
    Lee, Hye Ja
    Park, Mi Kyung
    Lee, Eun Ji
    Lee, Chang Hoon
    INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY, 2013, 45 (12): : 2801 - 2807
  • [22] Alpha-Lipoic Acid-Me diate d Inhibition of LTB4 Synthesis Suppresses Epithelial-Mesenchymal Transition, Modulating Functional and Tumorigenic Capacities in Non-Small Cell Lung Cancer A549 Cells
    Torres, Maria Jose
    Rios, Juan Carlos
    Valle, Alexandra
    Indo, Sebastian
    Brockway, G. V. Kevin
    Lopez-Moncada, Fernanda
    Faundez, Mario
    Castellon, Enrique A.
    Contreras, Hector R.
    CURRENT THERAPEUTIC RESEARCH-CLINICAL AND EXPERIMENTAL, 2025, 102